about
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial.Upper gastrointestinal bleeding in Scotland 2000-2010: Improved outcomes but a significant weekend effect.Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation.Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.Hepatic granulomas: a 10 year single centre experience.Endoscopic ultrasound-guided elastography in the nodal staging of oesophageal cancerRestrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials.U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemiaComparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study.Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.Acute upper gastrointestinal bleeding in the elderly: aetiology, diagnosis and treatment.Variceal rebleeding: use of drug therapy and endoscopic band ligation.The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding.Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population.Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.Factors associated with spontaneous clearance of chronic hepatitis C virus infection.Risk assessment scores for patients with upper gastrointestinal bleeding and their use in clinical practice.Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study.Outpatient management of low-risk patients with upper gastrointestinal bleeding: can we safely extend the Glasgow Blatchford Score in clinical practice?Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia.Underdiagnosis of hereditary haemochromatosis: reflects lack of clinical not biochemical penetrance.Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.Is the Glasgow Blatchford score useful in the risk assessment of patients presenting with variceal haemorrhage?Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage.Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding.International prospective observational study of upper gastrointestinal haemorrhage: Does weekend admission affect outcome?The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen.Relationship of time to presentation after onset of upper GI bleeding with patient characteristics and outcomes: a prospective study.Mediastinal node staging by positron emission tomography-computed tomography and selective endoscopic ultrasound with fine needle aspiration for patients with upper gastrointestinal cancer: Results from a regional centre.Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study.
P50
Q33713993-7459752D-448B-44E1-90A3-30D54C04B8ECQ34498454-253123DE-15CE-4C9E-AE89-3EFCAA6E8703Q34906599-EC10B3EF-4A49-49FD-B30F-A038F3C4E354Q35349306-4BA69780-7253-4FBA-9458-AF132C92AC61Q35573102-0127F8CD-9A79-48A4-8F80-71037BF168BAQ35576620-89E49EDD-FEE3-4C26-8AA1-E9857B960937Q35813466-55F3AD2F-8E9D-43DC-8CCE-8B7C410CC90EQ36342957-357E6BAC-336A-423D-AEA8-BFF45E64C7CFQ36374829-FBD61FB7-F415-438D-A049-1F326C86D2DCQ36932098-ECF68689-DD41-431C-B591-02120B55DE11Q37567350-02A296A4-AEB9-4608-80E1-0460B97764B3Q37995449-824E2781-99F0-43B4-B551-BA8BF87132DDQ38063422-DF77E287-55FA-46C6-B1E8-90B158B4D96DQ38175517-CCC7F82F-5DB8-416A-B19B-549875A096DFQ38764529-26CE1570-399D-42A6-945D-90DDEF1CA07AQ39469623-A6EDFAB6-C7B0-429A-B151-FE88DA0BCA20Q39705792-CA9FBEFA-1C9C-4C61-9C1E-3CC8CCB36E46Q39786377-B2A43FBB-E793-4BAE-8515-38D8AF6B9714Q40356950-336870DA-58E0-444B-9493-65A8AFD7D706Q40727448-9C2B1F57-BF12-4380-8525-6AD75F4D9C27Q41108388-9A065F5E-F728-4DAA-B637-E2C5FA35B941Q41140477-D085353E-11A0-4129-B1E6-FA22ECD245BBQ42159672-7A362EDF-B709-44F9-8B79-311802850C56Q42225904-5E1C1ED1-A424-482A-9CF0-C8D7EBD84F84Q42236591-6A760C73-C218-4EB7-BFBA-918314A935A6Q43005871-DF899B65-F3DD-4BF5-94C4-64CB4C22AB43Q43904253-DEBB4D94-F63E-4963-BAC8-E9D82ACEC510Q44116670-F1EB9E50-35AE-448B-80E5-8D2B9B91844AQ44174496-012B8783-D8F3-445E-8A4A-1A18D2F09FE6Q44203758-0CFC23F1-A63B-453E-93B7-B56422921393Q45354911-5A8669EC-E191-487C-997E-1FA21CC1643AQ45927000-165462DA-8F36-4638-A2AB-E719F8669187Q46915875-DA7BA79C-53FF-42F6-9ACD-40727188D8A7Q47163632-281BDB37-958B-4988-BC97-A321B94996B0Q47444876-8C85B1DB-0196-4C68-9B6E-43388C3C3B8FQ47752124-E37F0F98-82E3-4F5C-8ECD-1435556EE36DQ48521529-304D4540-157D-4B03-B865-2FCF259B746EQ49584039-50BCDCBF-9CA3-4EFC-94BA-AD4F704CF311Q50445966-2DAD271F-1211-41D4-A049-5C22E4A51420Q51050990-2C03FEF3-32F5-4617-AFD6-72DB7A8D12B6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adrian J. Stanley
@ast
Adrian J. Stanley
@en
Adrian J. Stanley
@es
Adrian J. Stanley
@nl
Adrian J. Stanley
@sl
type
label
Adrian J. Stanley
@ast
Adrian J. Stanley
@en
Adrian J. Stanley
@es
Adrian J. Stanley
@nl
Adrian J. Stanley
@sl
prefLabel
Adrian J. Stanley
@ast
Adrian J. Stanley
@en
Adrian J. Stanley
@es
Adrian J. Stanley
@nl
Adrian J. Stanley
@sl
P106
P1153
57195213749
7102172999
P21
P31
P496
0000-0002-9761-9795